ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Effect of atorvastatin on kidney function in chronic kidney disease: A randomised double-blind placebo-controlled trial
Atherosclerosis
◽
10.1016/j.atherosclerosis.2010.07.053
◽
2010
◽
Vol 213
(1)
◽
pp. 218-224
◽
Cited By ~ 36
Author(s):
Robert G. Fassett
◽
Iain K. Robertson
◽
Madeleine J. Ball
◽
Dominic P. Geraghty
◽
Jeff S. Coombes
Keyword(s):
Chronic Kidney Disease
◽
Kidney Disease
◽
Kidney Function
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Related Documents
Cited By
References
Faculty Opinions recommendation of High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717954671.793466054
◽
2012
◽
Author(s):
John Eisman
Keyword(s):
Chronic Kidney Disease
◽
Parathyroid Hormone
◽
Kidney Disease
◽
Controlled Trial
◽
High Dose
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Faculty Opinions recommendation of Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.735542506.793559665
◽
2019
◽
Author(s):
Carmine Zoccali
◽
Davide Bolignano
Keyword(s):
Type 2 Diabetes
◽
Chronic Kidney Disease
◽
Kidney Disease
◽
Glycaemic Control
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
◽
Lowering Effect
Download Full-text
FP413EFFECT OF VITAMIN D SUPPLEMENTATION ON VASCULAR FUNCTION, ENDOTHELIAL AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL
Nephrology Dialysis Transplantation
◽
10.1093/ndt/gfv177.12
◽
2015
◽
Vol 30
(suppl_3)
◽
pp. iii205-iii208
Author(s):
Ashok Kumar Yadav
◽
Vivek Kumar
◽
Vinod Kumar
◽
Manphool Singhal
◽
Anupam Lal
◽
...
Keyword(s):
Chronic Kidney Disease
◽
Vitamin D
◽
Kidney Disease
◽
Vascular Function
◽
Controlled Trial
◽
Vitamin D Supplementation
◽
Inflammatory Biomarkers
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
The Lancet
◽
10.1016/s0140-6736(19)32135-x
◽
2019
◽
Vol 394
(10208)
◽
pp. 1540-1550
◽
Cited By ~ 44
Author(s):
Rajiv Agarwal
◽
Patrick Rossignol
◽
Alain Romero
◽
Dahlia Garza
◽
Martha R Mayo
◽
...
Keyword(s):
Chronic Kidney Disease
◽
Kidney Disease
◽
Resistant Hypertension
◽
Controlled Trial
◽
Phase 2
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial
The Lancet Diabetes & Endocrinology
◽
10.1016/s2213-8587(13)70208-0
◽
2014
◽
Vol 2
(5)
◽
pp. 369-384
◽
Cited By ~ 308
Author(s):
Anthony H Barnett
◽
Ambrish Mithal
◽
Jenny Manassie
◽
Russell Jones
◽
Henning Rattunde
◽
...
Keyword(s):
Type 2 Diabetes
◽
Chronic Kidney Disease
◽
Kidney Disease
◽
Controlled Trial
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
Advances in Therapy
◽
10.1007/s12325-019-00943-4
◽
2019
◽
Vol 36
(6)
◽
pp. 1438-1454
◽
Cited By ~ 17
Author(s):
Tadao Akizawa
◽
Manabu Iwasaki
◽
Tetsuro Otsuka
◽
Michael Reusch
◽
Toshihiro Misumi
Keyword(s):
Chronic Kidney Disease
◽
Kidney Disease
◽
Controlled Trial
◽
Japanese Patients
◽
Phase 2
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trial
BMC Medicine
◽
10.1186/s12916-020-01542-9
◽
2020
◽
Vol 18
(1)
◽
Cited By ~ 5
Author(s):
Keyword(s):
Chronic Kidney Disease
◽
Cost Effectiveness
◽
Kidney Disease
◽
Older Patients
◽
Controlled Trial
◽
Low Grade
◽
Double Blind
◽
Double Blind Placebo
◽
Bicarbonate Therapy
◽
Oral Sodium
Download Full-text
Faculty Opinions recommendation of Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718462631.793518344
◽
2016
◽
Author(s):
Sydney Tang
◽
Gary Chan
Keyword(s):
Type 2 Diabetes
◽
Chronic Kidney Disease
◽
Kidney Disease
◽
Controlled Trial
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease
BMC Nephrology
◽
10.1186/1471-2369-12-9
◽
2011
◽
Vol 12
(1)
◽
Cited By ~ 6
Author(s):
Wajeh Qunibi
◽
Wolfgang C Winkelmayer
◽
Richard Solomon
◽
Moustafa Moustafa
◽
Paul Kessler
◽
...
Keyword(s):
Chronic Kidney Disease
◽
Kidney Disease
◽
Controlled Trial
◽
Calcium Acetate
◽
Serum Phosphorus
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Faculty Opinions recommendation of Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.736640403.793565817
◽
2019
◽
Author(s):
Carmine Zoccali
◽
Davide Bolignano
Keyword(s):
Chronic Kidney Disease
◽
Kidney Disease
◽
Resistant Hypertension
◽
Controlled Trial
◽
Phase 2
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close